COMMUNIQUÉS West-GlobeNewswire

ContraVir Pharmaceuticals Announces Completion of Phase 1 with CRV431
18/09/2018
EDISON, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
BioAegis Therapeutics Enrolls First Patients in Phase 1b/2a Community-Acquired Pneumonia Study and Raises $4 MM in Equity Round
18/09/2018
MORRISTOWN, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. announced that it has begun patient enrollment in a Phase 1b/2a study of recombinant plasma gelsolin (rhu-pGSN) in Community-Acquired [...]
Acasti Pharma Provides Clinical and Market Update
18/09/2018
TRILOGY phase 3 studies exceed 75% enrollment; on track to report topline results in 2019 LAVAL, Quebec, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator [...]
CBT Pharmaceuticals Initiates the APOLLO Oncology Clinical Trials Program
18/09/2018
First Patient Dosed in Initial Immunotherapy Combination Trial Utilizing CBT’s Proprietary Assets PLEASANTON, Calif. and HANGZHOU, China, Sept. 18, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), a U.S. and China- [...]
Avisa Reports on Progress with Biomarker AV BreathTest™ Platform
18/09/2018
Ten-minute, point-of-care breath test rapidly detects virulent bacterial infections to mitigate overuse of antibiotics and save hospital costs Proof-of-concept trial in Emergency Department pneumonia expected to be [...]
Hemispherx to Distribute Second Lot of Ampligen® for use in Multiple Indications in Argentina, the United States and Europe
18/09/2018
Ampligen supply will support product launch in Argentina, Expanded Access Programs for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the United States and Europe and pancreatic cancer in the [...]
ARCA biopharma Submits Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial
18/09/2018
Gencaro potentially the first genetically-targeted treatment for heart failure patients at risk for atrial fibrillation PRECISION-AF, planned Phase 3 clinical trial in patients with genotype that responds most favorably [...]
Agritek Holdings, Inc. Announces Filing Of Form 10-Q Report With Return To Fully Reporting Status On OTCQB And Update To Shareholders
18/09/2018
LOS ANGELES, CA, Sept. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector in the [...]
Wildflower Store Opening in New York’s Iconic Times Square in November
18/09/2018
VANCOUVER, British Columbia, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “ Company ”) is excited to announce that design work is completed for three prime locations in [...]
Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge
18/09/2018
Transaction to Create a Leader in Precision Oncology RUTHERFORD, N.J. and JERUSALEM, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology [...]
Zealand Pharma achieves primary and key secondary endpoints in pivotal Phase 3 trial with dasiglucagon for severe hypoglycemia
18/09/2018
Company announcement - No. 23/2018 Zealand Pharma achieves primary and key secondary endpoints in pivotal Phase 3 trial with dasiglucagon for severe hypoglycemia All primary and key secondary endpoints successfully [...]
Achaogen to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
18/09/2018
-- Company presentation scheduled for October 2, 2018 at 1:40 p.m. EDT -- SOUTH SAN FRANCISCO, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, [...]
Rexahn Pharmaceuticals to Present at the 5th NCI Pancreatic Cancer Symposium
18/09/2018
Preliminary Safety and Efficacy Data from the Ongoing Phase 2a Clinical Trial of RX-3117 in Combination with Abraxane® in Patients Newly Diagnosed with Metastatic Pancreatic Cancer will be presented ROCKVILLE, Md., Sept [...]
Gala Pharmaceutical to Form Strategic Alliances to Boost Demand for Cannabis Testing Facilities
18/09/2018
IRVINE, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, Inc. (Ticker: GLPH), an emerging cannabis testing company, today announced it expects to form strategic alliances with GreenGro Technologies ( [...]
CrownBio Licenses Translational Breast Cancer Models of Resistance and Metastasis
18/09/2018
SAN DIEGO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic [...]
Iterum Initiates SURE 2 and SURE 3 Phase 3 Clinical Trials of IV and Oral Sulopenem in Complicated Urinary Tract and Complicated Intra-abdominal Infections
18/09/2018
Remaining two of three planned Phase 3 pivotal trials now underway for Iterum’s lead antibiotic product candidate sulopenem Potential to be first and only oral and IV penem antibiotic available globally Top-line results [...]
Nemaura Signs Letter of Intent for SugarBEAT® Commercial Launch in Qatar
18/09/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by persons with diabetes [...]
resTORbio Appoints Meredith Manning as Chief Commercial Officer
18/09/2018
BOSTON, Sept. 18, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq:TORC), a clinical biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]
CrownBio octroie des licences de modèles de résistance et de métastase pour le cancer du sein translationnel
18/09/2018
SAN DIEGO, 18 sept. 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, une société mondiale de services de découverte et de développement de médicaments fournissant des plateformes translationnelles favorisant les progrès de la [...]

Pages